Solestial (Space Power Technology) Dossier

Operating as a private alternative energy equipment manufacturer in the aerospace sector, Solestial (Space Power Technology) secured $17,000,000 in Series A funding alongside a $1,200,000 SpaceWERX contract to scale its orbital power operations. Solestial (Space Power Technology) generates primary revenue through business-to-business sales of proprietary space-grade silicon solar cells and flexible solar power modules to commercial satellite operators, defense primes, and government agencies. The enterprise, headquartered in Tempe, Arizona, also secures non-dilutive research and development capital from the National Aeronautics and Space Administration and the National Science Foundation to support its core commercial space logistics clientele.

Financial Highlights

* Series A Capital Secured: $17,000,000

* SpaceWERX Contract Award: $1,200,000

* Target Price Per Watt: $20

* Annual Manufacturing Capacity: 1 Megawatt

* Module Specific Mass: 400 Grams Per Square Meter

* Cell Efficiency: 20 Percent

* Employee Headcount: 45 Personnel

Solestial (Space Power Technology) executes a low-cost pricing strategy designed to challenge legacy... Sign in / Sign up to learn more about Solestial, Inc.

Continue your research by chatting with our AI financial analyst about Solestial, Inc.. Ask follow-up questions, request specific analysis, or explore investment scenarios. All insights are grounded in verified financial data and SEC filings.

Start your analysis with these investor-focused questions:

• Following Solestial's $17 million Series A funding in FY2025, how is Solestial balancing the high capital intensity of scaling automated manufacturing to a 1 MW annual run rate while simultaneously driving unit costs down toward the $20 per watt target?
• Given the geopolitical supply chain constraints surrounding China's export ban on gallium and germanium, how can Solestial strategically leverage its proprietary silicon heterojunction technology to accelerate market share capture from legacy III-V multijunction competitors like Spectrolab?
• With Margo de Naray taking the CEO role to lead operational expansion, what specific manufacturing and commercialization metrics should investors monitor to evaluate Solestial's successful transition from an R&D-focused technology developer to a commercial-scale aerospace supplier?
• How does Solestial plan to optimize its revenue mix between federal defense contracts, such as the SpaceWERX initiative, and commercial space logistics operators to mitigate the financial risks associated with shifting government space budgets?
• Considering the extreme environmental risks inherent in space deployments, how does Solestial's low-temperature radiation self-curing capability translate into tangible, long-term financial advantages for satellite operators when evaluated against the proven flight heritage of traditional aerospace incumbents?